Medtronic, Inc. Stock Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 17 | Baird Adjusts Medtronic Price Target to $88 From $91 | MT |
Apr. 15 | Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says | MT |
Financials (USD)
Sales 2024 * | 32.24B | Sales 2025 * | 33.58B | Capitalization | 106B |
---|---|---|---|---|---|
Net income 2024 * | 4.55B | Net income 2025 * | 5.24B | EV / Sales 2024 * | 3.97 x |
Net Debt 2024 * | 22.3B | Net Debt 2025 * | 21.07B | EV / Sales 2025 * | 3.77 x |
P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
19.7
x | Employees | - |
Yield 2024 * |
3.46% | Yield 2025 * |
3.64% | Free-Float | 99.82% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 60 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
-2.53% | 183B | |
+5.33% | 51.77B | |
+16.43% | 47.29B | |
-1.73% | 40.2B | |
+5.66% | 27.62B | |
-2.01% | 25.51B | |
+9.84% | 24.73B | |
-1.87% | 24.52B | |
+9.12% | 22.68B |